Suppr超能文献

阻断致癌激酶PAK1的有效神经纤维瘤病疗法。

Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1.

作者信息

Maruta H

机构信息

NF/TSC Cure Org., Melbourne, Australia.

出版信息

Drug Discov Ther. 2011 Dec;5(6):266-78. doi: 10.5582/ddt.2011.v5.6.266.

Abstract

Neurofibromatosis (NF) is a family of genetic diseases which are caused by dysfunction of either NF1 gene or NF2 gene. One in 3,000 people suffer from this tumor-carrying NF. NF1 gene product is a RAS GTPase activating protein (GAP) of 2,818 amino acids, which normally attenuates the GTP-dependent signal transducing activity of the G protein RAS. Dysfunction of this GAP leads to the abnormal activation of RAS, and eventually an oncogenic kinase called PAK1 as well. NF2 gene product is ''Merlin'' which directly inactivates PAK1. Thus, dysfunction of Merlin causes the abnormal activation of PAK1. In other words, dysfunction of NF1 gene (causing type 1 NF) is basically the same as dysfunction of NF2 gene (causing type 2 NF). In fact the growth of both NF1 and NF2 tumors requires PAK1, and all PAK1 blockers, synthetic chemicals or natural products, suppress the growth of these NF tumor cells both in vitro (cell culture) and in vivo (mice). However, until recently, no FDA-approved effective NF therapeutics is available on the market. Here a series of anti-PAK1 products shall be introduced, which would be potentially useful for the life-long treatment of NF patients in the future. These include the most potent HDAC (histone deacetylase) inhibitor FK228 (IC: around 1 nM), that eventually blocks PAK1, the direct PAK1 inhibitor PF3758309 (IC: around 10 nM), a CAPE (caffeic acid phenethyl ester)-based propolis extract called ''Bio 30'' from NZ (New Zealand), and an ARC (artepillin C)-based green propolis extract (GPE) from Brazil. Although the first two drugs are potent, none of them is available on the market as yet. The last two natural (bee-made) products are available on the market, and have been used for the therapy of NF and tuberous sclerosis (TSC) as well as many PAK1-dependent solid cancers such as breast and pancreatic cancers as well as glioma, which altogether represent more than 70% of all human cancers. Since PAK1 is not essential for the normal cell growth, propolis extracts cause no side effects.

摘要

神经纤维瘤病(NF)是一类遗传性疾病,由NF1基因或NF2基因功能障碍引起。每3000人中就有1人患有这种携带肿瘤的神经纤维瘤病。NF1基因产物是一种由2818个氨基酸组成的RAS GTP酶激活蛋白(GAP),它通常会减弱G蛋白RAS的GTP依赖性信号转导活性。这种GAP功能障碍会导致RAS异常激活,最终还会导致一种名为PAK1的致癌激酶异常激活。NF2基因产物是“Merlin”,它直接使PAK1失活。因此,Merlin功能障碍会导致PAK1异常激活。换句话说,NF1基因功能障碍(导致1型NF)与NF2基因功能障碍(导致2型NF)基本相同。事实上,NF1和NF2肿瘤的生长都需要PAK1,所有PAK1阻滞剂,无论是合成化学物质还是天然产物,在体外(细胞培养)和体内(小鼠)都能抑制这些NF肿瘤细胞的生长。然而,直到最近,市场上还没有获得美国食品药品监督管理局(FDA)批准的有效的NF治疗药物。在此将介绍一系列抗PAK1产品,它们未来可能对NF患者的终身治疗有用。这些产品包括最有效的组蛋白去乙酰化酶(HDAC)抑制剂FK228(抑制常数:约1 nM),它最终会阻断PAK1;直接的PAK1抑制剂PF3758309(抑制常数:约10 nM);一种来自新西兰的基于咖啡酸苯乙酯(CAPE)的蜂胶提取物,名为“Bio 30”;以及一种来自巴西的基于阿替匹林C(ARC)的绿色蜂胶提取物(GPE)。虽然前两种药物效力强大,但它们都尚未上市。最后两种天然(蜜蜂制造)产品已在市场上有售,并且已用于治疗NF和结节性硬化症(TSC)以及许多PAK1依赖性实体癌,如乳腺癌、胰腺癌和神经胶质瘤,这些癌症总共占所有人类癌症的70%以上。由于PAK1对正常细胞生长并非必不可少,蜂胶提取物不会产生副作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验